Sort   by:  
 Page size 
ProteomicsHybrid QconCAT-based Targeted Absolute and Data-independent Acquisition-based Label-free Quantification Enables In-depth Proteomic Characterization of Wheat ATI Extracts
In this study, we present a novel hybrid data-independent acquisition LC-MS approach, combining QconCAT technology with short microflow LC gradients and DIA and apply the method towards the quantitative proteome analysis of ATI extracts from wheat flour. The novel method is fast, robust and reproduc...
ORGANISM(S): Triticum aestivum (Wheat) 
2021-04-22 | PXD021381 | Pride
Wheat Dia Data-independent acquisition Qconcat Absolute quantification Microflow lc-ms Ati Triticum Amylase-trypsin inhibitor 
ProteomicsTargeted LC−MS/MS Reveals Similar Contents of α‑Amylase/ Trypsin-Inhibitors as Putative Triggers of Nonceliac Gluten Sensitivity in All Wheat Species except Einkorn
Amylase/trypsin-inhibitors (ATIs) are putative triggers of nonceliac gluten sensitivity, but contents of ATIs in different wheat species were not available. Therefore, the predominant ATIs 0.19 + 0.53, 0.28, CM2, CM3, and CM16 in eight cultivars each of common wheat, durum wheat, spelt, emmer, and e...
ORGANISM(S): Triticum aestivum (Wheat) 
2019-02-22 | PXD012822 | Pride
Stable isotope dilution assay Modern and ancient wheats Mass spectrometry Α-amylase/trypsin-inhibitor Nonceliac gluten sensitivity 
GenomicsATI-1777 a topical JAK1/3 inhibitor may benefit atopic dermatitis without systemic drug exposure, results from preclinical development and Phase 2a randomized-control study ATI-1777-AD-201
ATI-1777 a topical JAK1/3 inhibitor may benefit atopic dermatitis without systemic drug exposure, results from preclinical development and Phase 2a randomized-control study ATI-1777-AD-201
PRJNA1021651 | ENA
TranscriptomicsATI-1777 a topical JAK1/3 inhibitor may benefit atopic dermatitis without systemic drug exposure, results from preclinical development and Phase 2a randomized-control study ATI-1777-AD-201
Atopic dermatitis (AD), a chronic, pruritic skin disease, affects 10%-30% of children and up to 14% of adults in developed countries. Since current AD treatments may lead to systemic drug exposure and AD pathophysiology is partially mediated by JAK1/3 signaling, ATI-1777, a potent and selective JAK1...
ORGANISM(S): Sus scrofa 
2023-11-20 | GSE244201 | GEO
GenomicsSequence determinants of human gene regulatory elements, ATI experiment
Sequence determinants of human gene regulatory elements, ATI experiment
PRJNA746770 | ENA
UnknownSea-ATI unravels novel vocabularies of plant active cistrome.
Not available
S-EPMC10681729 | biostudies-literature
UnknownATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201.
Not available
S-EPMC10825549 | biostudies-literature
UnknownPharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis.
Not available
S-EPMC10583688 | biostudies-literature
TranscriptomicsExpression data of Medicago truncatula Jemalong A17 roots treated with auxin transport inhibitors
Rhizobium and allied bacteria form symbiotic nitrogen-fixing nodules on legume roots. Plant hormones appear to play a role in nodule formation. We treated Medicago truncatula roots with auxin transport inhibitors (ATIs) N-(1-naphthyl)phthalamic acid (NPA) and 2,3,5-triiodobenzoic acid (TIBA) to indu...
ORGANISM(S): Medicago truncatula 
2011-03-26 | E-GEOD-27991 | biostudies-arrayexpress
UnknownSourdough Fermentation Degrades Wheat Alpha-Amylase/Trypsin Inhibitor (ATI) and Reduces Pro-Inflammatory Activity.
Not available
S-EPMC7404469 | biostudies-literature
Sort   by:  
 Page size